Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2011

Feb 25, 2011

31802_dirs_2011-02-25_f1358e88-5852-43df-a6e8-8f0d97885f40.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2011-02-23

Reporting Person: Drachman David J (Director, President and CEO and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-23 Common Stock M 40671 $1.3300 Acquired 321363 Direct
2011-02-23 Common Stock S 38541 $10.3500 Disposed 282822 Direct
2011-02-23 Common Stock S 100 $10.3600 Disposed 282722 Direct
2011-02-23 Common Stock S 800 $10.3650 Disposed 281922 Direct
2011-02-23 Common Stock S 600 $10.7500 Disposed 281322 Direct
2011-02-23 Common Stock S 20 $10.8900 Disposed 281302 Direct
2011-02-23 Common Stock S 210 $11.0100 Disposed 281092 Direct
2011-02-23 Common Stock S 400 $11.0300 Disposed 280692 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-23 Stock Option (right to buy) $1.3300 M 40671 Disposed 2012-10-14 Common Stock (40671) Direct

Footnotes

F1: These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).